These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18644162)

  • 1. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.
    Baratelli F; Takedatsu H; Hazra S; Peebles K; Luo J; Kurimoto PS; Zeng G; Batra RK; Sharma S; Dubinett SM; Lee JM
    J Transl Med; 2008 Jul; 6():38. PubMed ID: 18644162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells.
    Riedl K; Baratelli F; Batra RK; Yang SC; Luo J; Escuadro B; Figlin R; Strieter R; Sharma S; Dubinett S
    Mol Cancer; 2003 Nov; 2():35. PubMed ID: 14613584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.
    Yang SC; Hillinger S; Riedl K; Zhang L; Zhu L; Huang M; Atianzar K; Kuo BY; Gardner B; Batra RK; Strieter RM; Dubinett SM; Sharma S
    Clin Cancer Res; 2004 Apr; 10(8):2891-901. PubMed ID: 15102698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I Trial of Intratumoral Injection of
    Lee JM; Lee MH; Garon E; Goldman JW; Salehi-Rad R; Baratelli FE; Schaue D; Wang G; Rosen F; Yanagawa J; Walser TC; Lin Y; Park SJ; Adams S; Marincola FM; Tumeh PC; Abtin F; Suh R; Reckamp KL; Lee G; Wallace WD; Lee S; Zeng G; Elashoff DA; Sharma S; Dubinett SM
    Clin Cancer Res; 2017 Aug; 23(16):4556-4568. PubMed ID: 28468947
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector.
    Terando A; Roessler B; Mulé JJ
    Cancer Gene Ther; 2004 Mar; 11(3):165-73. PubMed ID: 14726959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Yang SC; Batra RK; Hillinger S; Reckamp KL; Strieter RM; Dubinett SM; Sharma S
    Cancer Res; 2006 Mar; 66(6):3205-13. PubMed ID: 16540672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression.
    Stefanski HE; Jonart L; Goren E; Mulé JJ; Blazar BR
    PLoS One; 2018; 13(4):e0193461. PubMed ID: 29617362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth.
    Kar UK; Srivastava MK; Andersson A; Baratelli F; Huang M; Kickhoefer VA; Dubinett SM; Rome LH; Sharma S
    PLoS One; 2011 May; 6(5):e18758. PubMed ID: 21559281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
    Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
    Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
    van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
    Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes.
    Sugaya M; Fang L; Cardones AR; Kakinuma T; Jaber SH; Blauvelt A; Hwang ST
    J Immunol; 2006 Dec; 177(11):7665-72. PubMed ID: 17114436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
    Salehi-Rad R; Lim RJ; Du Y; Tran LM; Li R; Ong SL; Ling Huang Z; Dumitras C; Zhang T; Park SJ; Crosson W; Kahangi B; Abascal J; Seet C; Oh M; Shabihkhani M; Paul M; Krysan K; Lisberg AE; Garon EB; Liu B; Dubinett SM
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
    Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE
    Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
    Gray JE; Chiappori A; Williams CC; Tanvetyanon T; Haura EB; Creelan BC; Kim J; Boyle TA; Pinder-Schenck M; Khalil F; Altiok S; Devane R; Noyes D; Mediavilla-Varela M; Smilee R; Hopewell EL; Kelley L; Antonia SJ
    Cancer Immunol Immunother; 2018 Dec; 67(12):1853-1862. PubMed ID: 30209589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
    Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
    Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.
    Chen P; Luo S; Wen YJ; Li YH; Li J; Wang YS; Du LC; Zhang P; Tang J; Yang DB; Hu HZ; Zhao X; Wei YQ
    Cancer Sci; 2014 Nov; 105(11):1393-401. PubMed ID: 25230206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
    Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
    Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage.
    Perrot I; Blanchard D; Freymond N; Isaac S; Guibert B; Pachéco Y; Lebecque S
    J Immunol; 2007 Mar; 178(5):2763-9. PubMed ID: 17312119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.